The spectrum of histopathological features in acute generalized exanthematous pustulosis: A study of 102 cases

British Journal of Dermatology

Volumn 163, Issue 6, 2010, Pages 1245-1252

  Halevy, S ^a   Kardaun, S H ^b   Davidovici, B ^a   Wechsler, J ^c  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

acute generalized exanthematous pustulosis; AGEP; cutaneous adverse drug reaction; histopathology

Indexed keywords

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; ARTICLE; CONTROLLED STUDY; EOSINOPHIL; ERYTHEMA; EXOCYTOSIS; HISTOPATHOLOGY; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; HYPERKERATOSIS; KERATINOCYTE; MAJOR CLINICAL STUDY; MITOSIS; NEUTROPHIL CHEMOTAXIS; PAPILLEDEMA; PARAKERATOSIS; PRIORITY JOURNAL; PSORIASIS; PUSTULE; RETROSPECTIVE STUDY; SKIN BIOPSY; SKIN EDEMA; VASCULITIS;

ACUTE DISEASE; EPIDERMIS; EXANTHEMA; FEMALE; HUMANS; MALE; RETROSPECTIVE STUDIES;

EID: 78649680350     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.09967.x     Document Type: Article

References (46)

1. Beylot C, Bioulac P, Doutre MS,. [Acute generalized exanthematic pustuloses (four cases)]. Ann Dermatol Venereol 1980; 107: 37-48.
2. Sidoroff A, Dunant A, Viboud C, et al. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br J Dermatol 2007; 157: 989-96.
3. Davidovici BB, Pavel D, Cagnano E, et al. Acute generalized exanthematous pustulosis following a spider bite: report of 3 cases. J Am Acad Dermatol 2006; 55: 525-9.
4. Davidovici BB, Naveh HP, Cagnano E, et al. [Acute generalized exanthematous pustulosis (AGEP) following intake of furosemide]. Harefuah 2006; 145: 477-9.
5. Davidovici B, Dodiuk-Gad R, Rozenman D, et al. Profile of acute generalized exanthematous pustulosis in Israel during 2002-2005: results of the RegiSCAR Study. Isr Med Assoc J 2008; 10: 410-12.
6. Halevy S,. Acute generalized exanthematous pustulosis. Curr Opin Allergy Clin Immunol 2009; 9: 322-8.
7. Rouchouse B, Bonnefoy M, Pallot B, et al. Acute generalized exanthematous pustular dermatitis and viral infection. Dermatologica 1986; 173: 180-4.
8. Naides SJ, Piette W, Veach LA, et al. Human parvovirus B19-induced vesiculopustular skin eruption. Am J Med 1988; 84: 968-72.
9. Haro-Gabaldon V, Sanchez-Sanchez-Vizcaino J, Ruiz-Avila P, et al. Acute generalized exanthematous pustulosis with cytomegalovirus infection. Int J Dermatol 1996; 35: 735-7.
10. Feio AB, Apetato M, Costa MM, et al. [Acute generalized exanthematous pustulosis due to Coxsackie B4 virus]. Acta Med Port 1997; 10: 487-91.
11. Lerch M, Bircher AJ,. Systemically induced allergic exanthem from mercury. Contact Dermatitis 2004; 50: 349-53.
12. Belhadjali H, Mandhouj S, Moussa A, et al. Mercury-induced acute generalized exanthematous pustulosis misdiagnosed as a drug-related case. Contact Dermatitis 2008; 59: 52-4.
13. Roujeau JC, Bioulac-Sage P, Bourseau C, et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 1991; 127: 1333-8.
14. Roujeau JC,. Clinical heterogeneity of drug hypersensitivity. Toxicology 2005; 209: 123-9.
15. Staughton RC, Payne CM, Harper JI, et al. Toxic pustuloderma-a new entity? J R Soc Med 1984; 77 (Suppl. 4): 6-8.
16. Rustin MH, Robinson TW, Dowd PM,. Toxic pustuloderma: a self-limiting eruption. Br J Dermatol 1990; 123: 119-24.
17. Bissonnette R, Tousignant J, Allaire G,. Drug-induced toxic pustuloderma. Int J Dermatol 1992; 31: 172-4.
18. Macmillan AL,. Generalised pustular drug rash. Dermatologica 1973; 146: 285-91.
19. Shelley ED, Shelley WB,. The subcorneal pustular drug eruption: an example induced by norfloxacin. Cutis 1988; 42: 24-7.
20. Lotem M, Ingber A, Segal R, et al. Generalized pustular drug rash induced by hydroxychloroquine. Acta Derm Venereol 1990; 70: 250-1.
21. Lazarov A, Livni E, Halevy S,. Generalized pustular drug eruptions: confirmation by in vitro tests. J Eur Acad Dermatol Venereol 1998; 10: 36-41.
22. Baker H, Ryan TJ,. Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases. Br J Dermatol 1968; 80: 771-93.
23. Whittam LR, Wakelin SH, Barker JN,. Generalized pustular psoriasis or drug-induced toxic pustuloderma? The use of patch testing. Clin Exp Dermatol 2000; 25: 122-4.
24. Burrows NP, Russell Jones RR,. Pustular drug eruptions: a histopathological spectrum. Histopathology 1993; 22: 569-73.
25. Spencer JM, Silvers DN, Grossman ME,. Pustular eruption after drug exposure: is it pustular psoriasis or a pustular drug eruption? Br J Dermatol 1994; 130: 514-19.
26. Smith K, Norwood C, Skelton H,. Do the physical and histologic features and time course in acute generalized exanthematous pustulosis reflect a pattern of cytokine dysregulation? J Cutan Med Surg 2003; 7: 7-12.
27. Cohen AD, Cagnano E, Halevy S,. Acute generalized exanthematous pustulosis mimicking toxic epidermal necrolysis. Int J Dermatol 2001; 40: 458-61.
28. Kardaun SH, De Monchy JG,. Acute generalized exanthematous pustulosis caused by morphine, confirmed by positive patch test and lymphocyte transformation test. J Am Acad Dermatol 2006; 55: S21-3.
29. Paradisi A, Bugatti L, Sisto T, et al. Acute generalized exanthematous pustulosis induced by hydroxychloroquine: three cases and a review of the literature. Clin Ther 2008; 30: 930-40.
30. Mockenhaupt M, Viboud C, Dunant A, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol 2008; 128: 35-44.
31. Kardaun SH, Sidoroff A, Valeyrie-Allanore L, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 2007; 156: 609-11.
32. Valeyrie-Allanore L, Poulalhon N, Fagot JP, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis induced by amifostine during head and neck radiotherapy. Radiother Oncol 2008; 87: 300-3.
33. Sidoroff A, Halevy S, Bavinck JN, et al. Acute generalized exanthematous pustulosis (AGEP)-a clinical reaction pattern. J Cutan Pathol 2001; 28: 113-19.
34. Rockl H,. [Leukocytoclastic vasculitis due to drug allergy presenting as generalized pustular exanthema]. Hautarzt 1981; 32: 467-70.
35. Mobini N, Toussaint S, Kamino H,. Noninfectious erythematous, papular, and squamous diseases. In: Lever's Histopathology of the Skin (, Elder DE, Elenitsas R, Johnson BL Jr. Murphy GF, eds), 9th edn. Philadelphia: Lippincott Williams & Wilkins, 2005; 179-214.
36. Ackerman AB, Böer A, Bennin B, Gottlieb GJ,. Histologic Diagnosis of Inflammatory Skin Diseases, 3rd edn. New York: Ardor Scribendi, 2005.
37. Beylot C, Doutre MS, Beylot-Barry M,. Acute generalized exanthematous pustulosis. Semin Cutan Med Surg 1996; 15: 244-9.
38. Ramdial PK, Naidoo DK,. Drug-induced cutaneous pathology. J Clin Pathol 2009; 62: 493-504.
39. Pichler WJ, Yawalkar N, Britschgi M, et al. Cellular and molecular pathophysiology of cutaneous drug reactions. Am J Clin Dermatol 2002; 3: 229-38.
40. Britschgi M, Pichler WJ,. Acute generalized exanthematous pustulosis, a clue to neutrophil-mediated inflammatory processes orchestrated by T cells. Curr Opin Allergy Clin Immunol 2002; 2: 325-31.
41. Britschgi M, Steiner UC, Schmid S, et al. T-cell involvement in drug-induced acute generalized exanthematous pustulosis. J Clin Invest 2001; 107: 1433-41.
42. Schaerli P, Britschgi M, Keller M, et al. Characterization of human T cells that regulate neutrophilic skin inflammation. J Immunol 2004; 173: 2151-8.
43. Horn TD, Hiatt KM,. Cutaneous toxicities of drugs. In: Lever's Histopathology of the Skin (, Elder DE, Elenitsas R, Johnson BL Jr. Murphy GF, eds), 9th edn. Philadelphia: Lippincott Williams & Wilkins, 2005; 324-45.
44. Meiss F, Helmbold P, Meykadeh N, et al. Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor-alpha antibody infliximab: report of three cases. J Eur Acad Dermatol Venereol 2007; 21: 717-19.
45. Schmid S, Kuechler PC, Britschgi M, et al. Acute generalized exanthematous pustulosis: role of cytotoxic T cells in pustule formation. Am J Pathol 2002; 161: 2079-86.
46. Pang BK, Su D, Ratnam KV,. Drug-induced purpura simplex: clinical and histological characteristics. Ann Acad Med Singapore 1993; 22: 870-2.